Omega Fund VI, L.P.

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

Stocks Covered

Latest Filing

Feb 14, 2025

Filings

LXEO

Lexeo Therapeutics, Inc.

SC 13G/A · Feb 14, 2025

3.6%

1.2M shares

IKNA

Ikena Oncology, Inc.

SC 13G/A · Feb 14, 2024

4.7%

2.2M shares

ALPN

Alpine Immune Sciences, Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

LXEO

Lexeo Therapeutics, Inc.

SC 13G · Feb 14, 2024

8.1%

2.2M shares

ALPN

Alpine Immune Sciences, Inc.

SC 13G/A · Feb 13, 2023

5.2%

2.4M shares

ALPN

Alpine Immune Sciences, Inc.

SC 13G/A · Feb 14, 2022

8.2%

2.4M shares

IKNA

SC 13G 1 d244282dsc13g.htm SC 13G SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 Ikena Oncology, Inc.

SC 13G · Feb 14, 2022

6.3%

2.2M shares

IMGO

SC 13G 1 d63577dsc13g.htm SC 13G SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 Imago BioSciences, Inc.

SC 13G · Feb 14, 2022

9.0%

3.0M shares